Podcasts about medical affairs

It's back-to-school szn, and while some kids are stressing over earlier wake-ups, this year's incoming medical students have a bigger question to answer: how do you train for a career that could still have you practicing medicine in the 2070s, when the tools of medicine are changing so rapidly?For our back-to-school episode, we sat down with Stanford University School of Medicine Dean Dr. Lloyd Minor to talk about how AI is already reshaping what future doctors learn and how they're taught, as well as what's still not working in American healthcare.We cover:What medical students are actually being taught about AI, and where Stanford still draws the lineWhy Stanford's tumor boards no longer start with humansThe surprising way Dr. Minor thinks AI could level the playing field in healthcare accessWhy the same AI tools helping patients feel more informed are also making them more anxiousThe counterintuitive reason new medical technology gets more expensive before it gets cheaperWhat's still standing in the way of a vision for precision medicine that's been decades in the makingAbout our guest:Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health.In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.In 2012, Dr. Minor was elected to the National Academy of Medicine.—

Organizations demand infinite growth in finite markets. Leaders are left at the crossroads of irreconcilable missions, balancing economic imperatives with the well-being of their teams. What happens when the equation simply has no solution? The cost of execution is sometimes your own breaking point.Welcome to Pharma Minds, Summer Series "Executing differently takes courage". For this final episode of our miniseries, I wanted to explore what execution reveals about oneself at the deepest level. I chose to speak with Patrice because his journey shows what it concretely costs to actually do what you said you would do. Execution eventually ceases to be a professional requirement. It becomes a personal decision to put skin in the game, without a safety net, but with singular intention. Patrice Zagame is the Founder and CEO of Eolias Health, an OTC lab for plant-based products aimed at the Brazilian market. After spending 35 years in the pharmaceutical industry and managing global subsidiaries for 16 years, he knows the weight of impossible contexts. From handling severe price cuts and sales force reductions in France to surviving executive burnout and ultimately funding his own venture, Patrice embodies the courage of leaving the comfort of a massive organization to truly walk the talk.In this episode, we cover:◾️The Impossible Equation : Balancing double-digit growth demands with saturated markets and massive price cuts.◾️Choice Versus Chance : Why letting an organization dictate your pace can cost you the most crucial turns in your career.◾️The Silent Break : Recognizing the boiling point of executive burnout and walking away to change the equation.◾️Managing the Smartest Room : Stepping back from ego to lead experts who know more than you do.◾️Walking the Talk : Leaving corporate security to fund an entrepreneurial venture from scratch.Commitment is not a corporate posture. It is a daily decision renewed in the face of impossible contexts. At some point, managing the system is no longer enough. 

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: American healthcare is at a crossroads, and the decisions we make now will define the health of generations to come.Dr. Marschall Runge has spent more than four decades at the center of that challenge, serving as former CEO of Michigan Medicine, Dean of the University of Michigan Medical School, and EVP for Medical Affairs.A practicing cardiologist trained at Johns Hopkins and Massachusetts General Hospital, Dr. Runge brings both the scientist's rigor and the leader's vision to one of the most urgent conversations of our time.In his Amazon and USA Today bestselling book, "The Great Healthcare Disruption," he lays out a bold prescription for reimagining American medicine through AI, innovation, and courageous systemic change.Join us to discover what it truly takes to transform healthcare from the inside out. Let's go!Episode Highlights:Dr. Runge never planned to be a CEO, initially dismissing healthcare leaders before serendipity shaped his path.His personal hospital-at-home experience after hip surgery confirmed that recovery is faster, cheaper, and better at home.Ambient AI, which auto-generates clinical notes, is the one decision at Michigan Medicine that faced almost no dissent.America's top-tier quaternary care leads the world; the real crisis is access, not quality.AI can address the clinician shortage in a year or two, something traditional training pipelines need decades to solve.About our Guest:Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs.Dr. Runge is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. Dr. Runge is board-certified in internal medicine and cardiovascular diseases and has spoken and published widely on topics in clinical cardiology and vascular medicine.At the University of Michigan, Dr. Runge began serving as the executive vice president for medical affairs in March 2015 and, in January 2016, he was also appointed as the dean of the Medical School. He is the first person to serve in this combined position created by the Regents for the purpose of strengthening the integration between the Medical School and health care delivery in our hospitals and health centers.During his tenure in these leadership roles, Dr. Runge has implemented transformative change and positioned Michigan Medicine and the Medical School for continued success. Notable achievements during this period include: a significant expansion of Michigan Medicine's clinical network in the state, through integration of two health systems, the former Metro Health in Grand Rapids and Sparrow Health System in Lansing, multiple joint ventures with Trinity Health, launch of the Precision Health Initiative, a major research collaboration with several other U-M schools and colleges; oversight of the conclusion of the Victors for Michigan campaign which raised $1.5 billion dollars for institutional strategic priorities; and the development and implementation of Michigan Medicine's first strategic plan for diversity, equity and inclusion in support of the broader university-wide DEI initiative.Under Dr. Runge's leadership, the University of Michigan Health's adult hospitals were ranked best in Michigan in 2023-2024 in U.S. News & World Report “Best Hospitals” rankings, the 31st consecutive year that U-M Health has been nationally recognized for strong across-the-board performance. In Newsweek's 2024 ranking of America's Best Hospitals, U-M Health ranked #1 in the state and #3 in the country.Current and new initiatives under Dr. Runge's leadership include construction of the The D. Dan and Betty Kahn Health Care Pavilion, a 12-story and 264 private room inpatient hospital; working to reduce faculty and staff burnout; executive rounding to help promote employee engagement and retention; establishment of the Heart Brain Institute and Global Health; oversight and development of the Anti-Racism Oversight Committee to help achieve an anti-racist culture; improved access and patient experience through the M2C2 Capacity Center; and the establishment of the Care at Home initiative which focuses on providing safe, hospital-level care to patients in their own home.Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in health care.Links Supporting This Episode: Dr. Marschall Runge Website: CLICK HEREDr. Marschall Runge LinkedIn page: CLICK HEREThe Great Healthcare Disruption book link: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Every surgical procedure depends on a reliable barrier between clinicians and patients, but is every glove designed to deliver the same level of protection? On this week's First Case Vendor Spotlight™, Rachel Dalton, MSN, RN, CPPS, Global Manager of Medical Affairs at Cardinal Health™, discusses how the Protexis™ Surgical Glove Portfolio is helping OR teams stay ahead of evolving best practices around glove changing, double-gloving, and latex-free surgical environments. With features like Neu-Thera™ coating, independent thumb design, and interlocking beaded cuffs, the Protexis™ Portfolio helps support comfort, dexterity, and reliable protection throughout every procedure. From product innovation to hands-on clinical support, discover how Cardinal Health™ is helping OR teams build confidence in every layer of protection. Interested in bringing the Protexis™ Surgical Gloves Portfolio to your facility? Connect with your Cardinal Health™ sales representative or visit their website to request free samples, access CE courses, white papers, additional resources, and more. Plus, be sure to check out their previous Vendor Spotlight™ episodes featuring the Protexis™ Portfolio for even more insights. Tune in today! Tune in to previous Vendor Spotlight™ episodes here: Fits Like a Glove: The Performance & Protection of Latex-Free Gloves – Listen Here! Caring for the Hands that Heal: Identifying the Impact of High-Quality Surgical Gloves - Listen Here!

What if the key to strengthening rural healthcare isn't doing more—but working smarter, together?In this episode of the California State Rural Health Association Podcast, we bring you a thought-provoking conference panel featuring Sylvia Trujillo, healthcare policy and regulatory attorney and leader at the California Telehealth Resource Center (CTRC), and Dr. Martin Entwistle, Chief of Medical Affairs at Marshall Medical Center. Together, they explore how rural healthcare organizations can move beyond simply adopting technology to building sustainable, scalable systems that improve patient care while protecting the future of rural hospitals.Drawing on Marshall Medical Center's real-world experience, Dr. Entwistle shares how his team shifted from fragmented digital initiatives to a comprehensive strategy centered on telehealth, remote patient monitoring, artificial intelligence, and value-based care. Rather than chasing every new technology, they focused on governance, infrastructure, partnerships, and workflows that could grow with their organization and support long-term success.The conversation also tackles some of rural healthcare's biggest challenges—including workforce shortages, reimbursement, interoperability, financial sustainability, and the risk of losing patients to larger health systems. Sylvia explains how collaboration, strategic planning, and the California Rural Health Transformation Fund can help organizations build stronger regional networks that keep specialty care and healthcare dollars within rural communities.Whether you're leading a rural hospital, community health center, clinic, or healthcare organization, this episode offers practical insights on:Building scalable digital health programs instead of isolated projectsUsing telehealth and remote patient monitoring to improve access and outcomesCreating successful hub-and-spoke partnerships that strengthen rural carePreparing for value-based care and future reimbursement modelsLeveraging available funding and no-cost technical assistance to support digital transformationIf you're wondering how rural healthcare can remain financially viable while embracing innovation, this conversation provides both a roadmap and a call to action.Listen now to discover how strategic partnerships, thoughtful planning, and digital transformation can help rural communities deliver better care—without leaving patients behind.What You'll Learn From This Episode:CTRC Mission and Audience PulseMarshall Case for Virtual CareHub and Spoke PartnershipsBuilding Infrastructure to ScaleRural Transformation Fund TakeawaysThe CSRHA has been a go-to resource for rural healthcare and community leaders since 1995. The CSRHA brings an accumulation of actionable insights to the next generation of rural healthcare leaders. For more behind the scenes of this podcast follow @CSRHApodcast on Twitter or @csrha.advocate on Facebook.If you enjoy This Is Rural Health, we could use your support! Please consider leaving a 5-star rating and review, and share it with someone who needs to hear this!Learn more about the CSRHA at csrha.org.Connect with Sylvia Trujillo:LinkedInConnect with Martin Entwistle:LinkedInResourcesCalifornia Telehealth Resource CenterCalifornia State Office of Rural HealthU.S. Department of Health & Human ServicesMarshall Medical Center

The FDA finalized its guidance on Scientific Information on Unapproved Uses (SIUU) in January 2025, giving pharmaceutical and biotech companies a framework for proactive off-label communication with healthcare providers. Yet many medical affairs organizations are still navigating what it means in practice. In this episode, Peg Crowley-Nowick, PhD, MBA talks with Josh Bryson, PhD, Head of U.S. Medical Affairs and Evidence Generation at Argenx, about the real-world implications for medical affairs strategy. Josh and Peg examine what the FDA guidance permits, the data integrity and publication requirements that must be in place, and how the shift from reactive to proactive scientific exchange changes HCP engagement. They also discuss how SIUU raises the bar for evidence generation, driving companies to think more deliberately about data quality, study design, and publication strategy in order to meet the criteria the guidance requires. Medical Science Liaisons and Medical Affairs leaders will find this conversation directly relevant to how they approach both field engagement and evidence planning. A practical conversation for medical affairs professionals looking to understand how the FDA off-label communication guidance reshapes communications strategy and the evidence needed to support it.

Before menopause, our risk of heart disease is HALF what a man's is. Within a few years of our last period, it is EQUAL. By our seventies, it is HIGHER. So why is nobody screening us for it? This is the conversation midlife women have been waiting for. I sat down with Dr. Jayne Morgan, a research cardiologist and Vice President of Medical Affairs at Hello Heart, who is calling out menopause itself as the most missed opportunity in preventive cardiology. She is the creator of the Stairwell Chronicles, a science communicator who translates complex cardiology into kitchen-table language, and she has spent 25+ years researching what is actually happening to our hearts in midlife. This is our fourth cardiologist on the show. And she is different. She brings the research, the data, and a fierce honesty about why our healthcare system was built around the male body, and what we do about it now.   WE GO DEEP ON: • Why menopause is a CARDIOVASCULAR event, not a gynecologic footnote • The half / equal / greater stat that every midlife woman needs to memorize • The 37-minute delay women face in the ER for cardiac care, and the exact phrase that gets you seen • Why hot flashes, night sweats, palpitations, and brain fog are cardiovascular signals, not just inconveniences • What estrogen actually does for your heart and what happens when it drops, and the 10-year HRT window • Her take on statins, the online backlash, and what the research actually says about LDL • What to do if you tried a statin and felt terrible — • Why it is LDL AND insulin resistance AND inflammation — not one versus the other • The labs to demand: ApoB, Lp(a), hs-CRP, fasting insulin, CAC scan • Why women were excluded from cardiovascular clinical trials until 1993, and how that built the entire field on the wrong data • The exact advocacy phrase that gets your concern documented in your chart • Three things you can do this week that actually move the needle   This is not a doom episode. This is the conversation you bring to your doctor tomorrow.   TIMESTAMPS: • 00:00 — Why menopause is a cardiovascular event • 12:00 — The symptoms women miss and the 37-minute ER delay • 26:00 — Estrogen, HRT and the 10-year window • 42:00 — LDL, cholesterol and the statin debate • 54:00 — What to test, what to track, what to demand • 66:00 — Health equity and self-advocacy • 76:00 — Three things this week   Catch the full episode on YOUTUBE HERE: https://bit.ly/MidlifeConversationsYouTube    Learn More About Dr. Jayne Morgan  Instagram ➜ http://www.instagram.com/drjaynemorgan   Website ➜   https://drjaynemorgan.com/ Hello Heart➜   https://www.helloheart.com/      Thank you to our show sponsors:  LEELA QUANTUM:  Get 10% off your first Leela Quantum order with the code NatalieJill at checkout  at https://midlifeconversations.com/leela TIMELINE: Timeline is offering 20% off your order of Mitopure! Go to https://timeline.com/NATALIEJILL  BIOPTIMIZERS: Stop settling for one form of magnesium when your body needs all 7. This one has them all! Get yours at https://bioptimizers.com/nataliejill  and use code NATALIEJILL to save  Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

Medical affairs is at an inflection point. As science advances and healthcare professionals gain access to information in real time, medical teams face a mandate to deliver insight with greater speed, relevance and impact. In this episode of The Top Line, Josh Schwartz, Vice President of Medical Affairs, North America at BeOne Medicines, and Jalpa Shah, who leads the medical and evidence practice at ZS Pharma discuss what a modern medical affairs model requires. The conversation explores how the function is becoming a more strategic business driver and why traditional measures of activity are no longer enough to demonstrate value. The episode examines the structural challenges that continue to hold organizations back, including fragmented data systems, limited visibility into insights and the difficulty of translating engagement into measurable outcomes. It also looks at how artificial intelligence (AI) is reshaping workflows by helping teams generate insights faster, identify trends and inform next best actions. The discussion also considers the capabilities, operating models and cultural shifts medical affairs teams will need to keep pace with science and influence clinical practice. The central takeaway is clear: Future success will depend less on access to more data and more on the ability to turn intelligence into coordinated action.See omnystudio.com/listener for privacy information.

Join Dr. Aarathi Cholkeri-Singh, Executive Director & Chief Medical Officer – North America, Karl Storz and Veeva experts for a practical discussion on establishing and scaling a high-impact medtech medical affairs function, even during hiring freezes. We'll share real-world strategies for navigating EU MDR requirements and building diverse teams that drive clear business value across various organizational structures. Finally, we will share new report findings on the function's current state to help you quantify your strategic contribution, accelerate enterprise growth, and transition from functional execution to a core leadership pillar.

In this episode, guest host Dr. Sandra Rolfe (Optum) is joined by Carrie Haverty, President of the National Society of Genetic Counselors and Vice President of Medical Affairs and Clinical Strategy at Mirvie, to explore the critical role of interoperability in advancing genetic counseling and precision medicine. Together, they discuss how standardized, structured genomic data exchange can improve care coordination, reduce administrative burden, expand access to genetic counseling, and help integrate genomic information into routine clinical workflows.

Heart disease is the number one killer of women. Not breast cancer. Not ovarian cancer. Heart disease. And yet most women — and many of their doctors — still don't recognize it in time. Why? Because heart disease in women doesn't look the way we've been taught. No crushing chest pain. No dramatic collapse. Instead: fatigue, jaw pain, nausea, GI upset. Symptoms so commonly dismissed as anxiety or perimenopause that women leave emergency rooms undiagnosed, undertreated, and in danger. Here's what I've learned after 29 years as a hockey mom: every year I hear about another hockey mom who died from a heart attack. Women in their 50s. Some healthy, some not. The message from their families is always the same — "it was out of nowhere" or "it was sudden." But after interviewing some of the country's best preventive cardiologists, I know the truth: heart attacks don't just show up. They've been brewing for years. No one looked. That changes today. Dr. Jayne Morgan is one of the country's leading cardiologists and a fierce advocate for women's cardiovascular health. As Vice President of Medical Affairs at Hello Heart, she has made it her life's mission to change the trajectory of women's heart health — and she is here to tell you exactly what to watch for, what to ask your doctor, and what to do right now to protect your heart through menopause and beyond. In this episode we cover: — Why heart disease is dramatically underdiagnosed in women — How menopause accelerates cardiovascular risk and why the transition window matters — The symptoms of heart disease in women that are routinely missed or dismissed — What a heart-healthy lifestyle actually looks like for postmenopausal women — The tests and screenings every woman over 40 needs to ask for — Why your risk profile changes after your last period — and what to do about it This is the conversation that could save your life. Share it with every woman you know. Medical Disclaimer: By listening to this podcast, you agree not to use this podcast as medical advice or to make any lifestyle changes to treat any medical condition in yourself or others. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any of my guests on my podcast. Learn more about Dr. Jayne Morgan: IG: drjaynemorgan Hello Heart: https://www.helloheart.com/ Stay Connected with Jill Foos Wellness: Book your 60-minute Menopause Care Consultation: https://www.jillfooswellness.com/menopause-care-consult-page Follow on Instagram: @jillfooswellness Follow on Facebook: @jillfooswellness Follow on YouTube: @jillfooswellness Grab discounts on my favorite menopause wellness products: https://www.jillfooswellness.com/health-products Enjoy 20% savings and free shipping at Fullscript for your favorite supplements by leading brands: https://us.fullscript.com/welcome/jillfooswellness/store-start Subscribe to the JFW newsletter at www.jillfooswellness.com and receive your FREE Guide on How To Create Your Menopause Health Equation Ebook. Schedule your free 15-minute consultation here: https://calendly.com/jillfooswellness/15-minute-zoom-consultations If you're a Chicago-area midlife woman, check out the Chicago Menopause Collective, a nonprofit dedicated to navigating menopause locally with experts: https://chicagomenopausecollective.org

Relebogile Mabotja speaks to Rakesh Harribhai the Founder of Parkinson’s ZA and Dr. Nombini Habangana a Medical Affairs Director at AbbVie unpacking the rise of Parkinsons Disease in South Africa and the causes of late diagnosis and how to detect early signs and symptoms. Through multidisciplinary interventions the disease can be manage effectively and the value of community in the management of the disease. 702 Afternoons with Relebogile Mabotja is broadcast live on Johannesburg based talk radio station 702 every weekday afternoon. Relebogile brings a lighter touch to some of the issues of the day as well as a mix of lifestyle topics and a peak into the worlds of entertainment and leisure. Thank you for listening to a 702 Afternoons with Relebogile Mabotja podcast. Listen live on Primedia+ weekdays from 13:00 to 15:00 (SA Time) to Afternoons with Relebogile Mabotja broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/2qKsEfu or find all the catch-up podcasts here https://buff.ly/DTykncj Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Guest: Julianne LallyShow Notes:Type 1 diabetes doesn't start with symptoms, it starts silently. In this episode, early screening expert Julianne Lally reveals how autoantibody testing can detect risk years before diagnosis and why that window matters. Learn how early detection can reduce complications, what families should know about screening access, and how new innovations are working to make early screening the norm, not the exception.Guest Bio:Julianne Lally, DMSc, MHS, PA-C, is Associate Director of Medical Affairs at Breakthrough T1D. She focuses primarily on screening and early detection of type 1 diabetes, leads the Early Detection Pilot Program and facilitates healthcare professional education efforts. Julianne's professional interest in T1D stems directly from her own personal diagnosis at age twelve. Doctorate of Medical Science, Masters of Health Science, and Physician AssistantQuote:“It's really beautiful to think about a future where people are diagnosed in their doctor's office and not in the hospital or ICU.”Question of the Day:If you have a family history of autoimmune conditions, type 1 diabetes in particular. Have you ever considered screening for type 1 diabetes? Why or why not?On This Episode You Will Learn:Why early detection of type 1 diabetes is so important.How type 1 diabetes can be detected before symptoms develop..Common symptoms families should watch forHow screening for type 1 diabetes worksNew research and treatments that could delay or prevent the disease.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Julianne Lally!Website URL: Type 1 Diabetes Screening & Early DetectionInstagram URL: @BreakthroughT1DFacebook URL: Breakthrough T1D Twitter(X) URL: @BreakthroughT1DLinkedIn URL: linkedin.com/in/juliannemlally/

Welcome to IDEA Collider with your host, Rick Ritacco.  In this episode, we sit down with Sue Wood, a senior expert at IDEA Pharma with a PhD from Oxford and decades of experience translating complex scientific concepts into relevant narratives. Sue discusses the unique challenges biotechs face with early positioning, explaining why teams often struggle with the paradox of having immediate scientific certainty about a molecule but immense clinical uncertainty about its future.  We explore how to simplify scientific messaging without "dumbing it down," and Sue shares three proven strategies: reappropriating non-pharma nomenclature, evolving familiar drug classes, and focusing on tangible clinical outcomes. Sue also highlights the importance of cross-functional alignment, noting that a team's conviction to execute a narrative often matters more than having absolute precision.  Tune in to hear her hilarious origin story involving the Boston Globe and oat bran donuts, and learn actionable advice on what biotechs should immediately remove from their websites. Don't forget to Like, Share, Subscribe, Rate, and Review!    Keep up with Sue Wood; LinkedIn: https://www.linkedin.com/in/susan-wood-266631244/    Follow IDEA Pharma On; Website: https://www.ideapharma.com/    Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/

How Medical Affairs is regaining its power.

日劇/漫畫《一兆$遊戲》中，阿學和阿陽利用數位，創造出橫跨社群遊戲、媒體、零售、交通、通訊等行業的大企業，並用數位重新改寫這些產業的生態。 在這一集中，我們訪問到《醫知彼》的營運長乃嘉，分享他們如何利用數位和社群重新詮釋醫學事務，利用社群媒體、數位互動、遊戲與動畫等不同媒介去分別向民眾和醫療人員推廣醫療新知，並利用社群的力量去試圖改善醫療生態系。同時，乃嘉也和我們分享她擁有臨床證照卻不走臨床，念完博班卻沒有走上教職，反而選擇成為新創共同創辦人的職涯抉擇。   ⭐️ 醫知彼官網： https://www.penpeer.co/ ⭐️ 專屬台灣醫師的A-Pen AI： https://www.a-pen.co/apen-ai   ⭐️ 今年 BTBA 年會 將在7/11-7/12 在哈佛舉辦 年會網站 https://www.btbatw.org/2026/ 購票連結 https://www.tickettailor.com/events/btba/2137594   ✨ 生技來一刻感謝國科會與駐波士頓辦事處科技組贊助我們製作節目。我們也歡迎聽眾小額捐款生技來一刻，您的支持能幫助我們製作更優質的節目。https://www.paypal.com/US/fundraiser/charity/2101877 ✨ 節目連結、講者Linkedin連結請見留言處！感謝講者提供詳盡的延伸閱讀連結和文章！  

Send us Fan MailIn this episode of the Life Science Success Podcast my guest is Simran Padam, MD, APMMC, Executive Director of Medical Affairs at Worldwide Clinical Trials. A physician with 17+ years guiding global studies, she shares insights on medical monitoring, complex oncology and hematology programs, and the clinical judgment behind drug development highlighted in her newsletter, The Medical Monitor's Desk.00:00 Show Intro and Guest01:49 Simran Career Journey04:22 Why CRO Variety Matters05:48 What Medical Monitors Do08:04 Protocol vs Reality09:43 Physicians Role Evolving11:14 Better Trial Decisions13:31 Newsletter Behind Scenes16:09 LinkedIn Newsletter Reach17:07 From Science to Execution19:18 Therapeutic Specialization21:20 Collaboration Across Teams23:05 Capabilities for Future25:16 Rapid Fire Inspiration32:44 Where to Connect34:09 Podcast Outro

David Miller, MD, MPH, CEO of Michigan Medicine and EVP for Medical Affairs, University of Michigan joined Rich Helppie from The Common Bridge Podcast May 27 at the 2026 Mackinac Policy Conference to discuss how hospitals are always caring for their communities and always advancing the health of the state. To learn more, visit MIHospitals.org. To subscribe to The Common Bridge Podcast, visit thecommonbridge.com.

Welcome to Episode 4 of the SciTech Critical Evaluation of Literature and AI Series: “Smarter Summaries, Better Decisions: AI Across Medical Affairs"Medical Affairs teams handle a flood of scientific data, so how can AI help turn complexity into clarity? Join experts from the MAPS Scientific & Technical Knowledge Domain to discover how AI tools evaluate evidence for diverse functions, from field teams to HEOR and publications.In this session, you'll learn practical strategies for creating concise, decision-ready summaries and explore why context and clinical relevance must guide every AI-driven workflow. If you want to leverage AI to evaluate evidence, podcast is for you!Learning Objectives:Describe how AI tools adapt evidence evaluation for different Medical Affairs functionsExplore how field medical, medical communications, publications, medical information, and HEOR teams can prompt the same data set differently to generate outputs tailored to their specific needs.Demonstrate strategies to create concise, decision-ready summaries using AILearn practical prompting and structuring techniques that convert complex scientific literature into clear, stakeholder-specific deliverables that support better strategic and scientific decisions.Explain why context and applicability are essential in AI-enabled evidence workflowsUnderstand how role-specific context, intended use, and decision impact must guide both the prompting and interpretation of AI-generated outputs.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

Today, we are talking about a true paradigm shift in prenatal genetics. For decades, we've relied on cell-free DNA for screening, but when it came to definitive confirmation of fetal aneuploidy, we've had to counsel our patients through the anxiety and physical risks of invasive procedures like amniocentesis and CVS. But what if the line between screening and confirmation just blurred? In this episode, we are diving into an avant-garde, first-of-its-kind maternal blood test that is now actively in clinical use and may prove to rival traditional invasive testing for fetal aneuploidy confirmation: the Unity CONFIRM test. To break down the cutting-edge science, the clinical validity, and exactly what this means for your daily practice, I am thrilled to welcome Jen Hoskovec, the Vice President of Medical Affairs for BillionToOne. You might have recently seen her insights featured alongside Dr. Haywood Brown in Contemporary OB/GYN, and today, she's here with us. We're going to discuss the availability of this test, the technology that makes it possible, and what the next concrete steps are for integrating this into modern obstetrical care. Grab your coffee. Let's get into the science.1. https://www.contemporaryobgyn.net/view/haywood-brown-md-jennifer-hoskovec-explain-new-non-invasive-confirmatory-test2. Screening for Fetal Chromosomal Abnormalities PA; January 2026

At the SOAP meeting in Montreal, Desiree Chappell and Monty Mythen interview Dr. Marie Louise Meng, Assistant Professor of Anesthesiology at Duke University Department of Anesthesiology and her former cardio-obstetric fellow Liliane Ernst, assistant professor in the Obstetric and Gynecologic Anesthesia section Wake Forest University. The conversation focuses on cardio-obstetric anesthesia, hemodynamics, monitoring, and patient-centered care. Meng describes building multidisciplinary "pregnancy heart teams" to plan management for complex cardiac disease in pregnancy and reduce birth trauma. Ernst discusses research using the Premier database on preexisting atrial fibrillation in pregnancy (about 25 per 100,000 deliveries) and associated management and outcomes. They review cases including mechanical circulatory support with an Impella to prolong pregnancy and highlight knowledge gaps about placental perfusion and pulsatility, including Fontan physiology. Meng outlines individualized hemodynamic monitoring for labor and C-sections, emphasizes recognizing hypertensive instability, and details preeclampsia with severe features, its end-organ criteria, incidence, disparities, postpartum follow-up challenges, and potential use of remote monitoring and noninvasive cardiac output/SVR monitoring to guide therapy. Monty Mythen, founding editor-in-chief of TopMedTalk, is now Senior Vice President, Scientific Liaison, BD Advanced Patient Monitoring. He is also Emeritus Professor of Anaesthesia and Critical Care, University College London, UK. Desirée Chappell, former co-editor-in-chief of TopMedTalk, is now Director of Medical Affairs and Medical Science Liaison, BD Advanced Patient Monitoring. She is also a CRNA at NorthStar Anesthesia, USA. -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - EBPOM World Congress 2026

Host Polly Swingle is joined by Lauren Sauders, MOTR/L, CBIS, CSRS, and Vice President of Medical Affairs at Neurolutions, to talk about the IpsiHand device for stroke recovery.As an occupational therapist by training, Lauren has spent her entire career in adult neurorehabilitation. She began as a clinician at The Rehabilitation Institute of St. Louis, an affiliate of Washington University in St. Louis, where she worked alongside the research team that conceived IpsiHand in its earliest days. She helped author the initial study protocol and has grown with the company ever since - shepherding the technology through clinical trials, peer‑reviewed publications, and the regulatory pathway that earned IpsiHand both FDA Breakthrough Device designation and De Novo clearance. After clearance, she helped lead the organization through commercialization and into broader clinical adoption. Lauren has authored numerous publications and delivered presentations at national and international forums, but her most enduring focus is advocacy: ensuring that stroke survivors have evidence‑based access to therapies that meaningfully improve their quality of life. That mission is personal. Beyond the patients she has cared for, Lauren brought her grandmother into her own home during the COVID‑19 pandemic and cared for her after she sustained a severe stroke — an experience that deepened her understanding of the toll stroke takes on families as well as individuals. She is also a mother of three, including a child with a rare neurogenetic condition, and is a passionate advocate within the pediatric neuro-community as well. Her and her husband also share their home with three crazy dogs. When she isn't working or advocating, she can most often be found visiting family in Bermuda.Click the link below to visit the IpsiHand by Kandu website-https://www.neurolutions.com/Learn more about The Recovery Project!View our website at www.therecoveryproject.netCall us 855-877-1944 to become a patientFollow us on InstagramLike us on FacebookThanks for listening! 

Welcome to Episode 3 of the SciTech Critical Evaluation of Literature and AI Series: “Humans + AI: Making Sense of Scientific Papers at Scale"AI can read hundreds of scientific papers in minutes, but can it truly understand them? Join experts from the MAPS Scientific & Technical Knowledge Domain to explore how artificial intelligence is reshaping literature review in Medical Affairs.In this session, you'll learn what AI can and cannot do with scientific content, uncover practical applications of leading tools like CoPilot and Notebook LM. We'll also tackle common risks such as hallucinations and lack of context, and share strategies to validate AI outputs while keeping clinical judgment front and center. If you want to harness AI without losing the human touch, this webinar is for you!Learning Objectives:Understand what AI can—and cannot—do with scientific literatureExplain how AI processes papers using NLP and LLMs, and why clinical judgment remains essential.Explore practical applications of leading AI toolsReview the capabilities, pros, and cons of tools like CoPilot and Notebook LM for Medical Affairs workflows.Recognize limitations and risks in AI-driven literature reviewIdentify common issues such as hallucinations, lack of context, and strategies to validate AI outputs.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

In this episode, Jon Alford, CFO, UW Medicine and Vice President for Medical Affairs at the University of Washington, joins the podcast to discuss the evolving financial challenges facing academic medical centers, from labor costs to reimbursement pressures. He also shares how automation, operational efficiency, and frontline engagement are shaping his leadership approach in his new role.Learn more about relentlessly raising RCM yield here: https://med-metrix.com/?utm_source=beckers&utm_medium=podcast&utm_campaign=brand

In this episode, Claudia Lucchinetti, MD, VP of Medical Affairs and Dean of the UT Austin Dell Medical School, discusses building an AI-native academic medical center, expanding access to advanced care in Central Texas, and integrating research, education, and clinical care into one connected ecosystem.

Welcome to Episode 2 of the SciTech Critical Evaluation of Literature and AI Series: “Literature Never Sleeps: Staying Ahead Without Burning Out"Literature never sleeps and neither do the challenges of keeping Medical Affairs teams up to date.Join experts from the MAPS Scientific & Technical Knowledge Domain to discover practical strategies for managing the deluge of data. We'll explore how AI can accelerate evidence synthesis while highlighting its limitations and the critical role of human judgment. If you're looking for smarter ways to stay current, this podcast is for you!Learning Objectives:Identify key challenges in keeping Medical Affairs teams currentUnderstand the impact of preprints, grey literature, bibliometrics, and predatory journals on evidence appraisal.Evaluate the role and limitations of AI in literature reviewRecognize how AI can accelerate evidence evaluation while appreciating the need for human judgment and safeguards against errors.Apply best practices for confidentiality and critical assessment of AI outputsLearn practical steps to ensure secure data handling and train teams to validate AI-generated insights effectively.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

In this episode, Ilan Shapiro, MD, MBA, FAAP, FACHE, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President at AltaMed Health Services, joins the podcast to discuss breaking language barriers in healthcare and closing gaps between patients and providers. He shares how improving communication and cultural understanding can lead to better access, stronger relationships, and improved health outcomes.

In this episode, Ilan Shapiro, MD, MBA, FAAP, FACHE, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President at AltaMed Health Services, joins the podcast to discuss breaking language barriers in healthcare and closing gaps between patients and providers. He shares how improving communication and cultural understanding can lead to better access, stronger relationships, and improved health outcomes.

In this episode, Kelli Tice, MD, Vice President of Medical Affairs and Chief Health Improvement Officer at GuideWell and Florida Blue, joins the podcast to discuss navigating healthcare with limited resources while continuing to improve outcomes. She shares insights on advancing maternal health, the importance of thoughtful decision-making, and how leadership choices can create meaningful impact across populations and communities.

In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick speaks with Nick Sarlis, MD, PhD, FACP, Chief Medical Officer at Clara Biotech, about why successful biotech launches begin years before approval. Drawing on experience across six product launches and nine indications, Nick shares a practical CMO perspective on building medical affairs capabilities early, aligning scientific strategy across functions, and preparing organizations for launch success in today's biotech environment. Nick explains why "T-minus 30 months" is becoming the new standard for launch preparation and discusses the foundational role of medical affairs in shaping scientific narrative, publication strategy, KOL engagement, field medical deployment, and long-term evidence generation planning. The conversation also explores: • Early hiring strategy for medical affairs teams • Building experienced MSL and field medical capabilities • Aligning medical, commercial, and corporate communications • Publication planning and scientific congress engagement • Academic center and patient advocacy partnerships • Managing actionable MSL insights • Evidence generation planning beyond approval • Launch readiness in resource-constrained biotech organizations A practical, resource and strategy-focused discussion for biotech executives, CMOs, medical affairs leaders, MSLs, and clinical-stage companies considering commercialization.

In this episode, Kelli Tice, MD, Vice President of Medical Affairs and Chief Health Improvement Officer at GuideWell and Florida Blue, joins the podcast to discuss navigating healthcare with limited resources while continuing to improve outcomes. She shares insights on advancing maternal health, the importance of thoughtful decision-making, and how leadership choices can create meaningful impact across populations and communities.

In the final part of this 3-part series, experts from the MAPS Leadership and Management Domain wrap up their discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.

Menopause gets reduced to hot flashes, whispered about like it's a personal flaw, then brushed off in the exam room when symptoms don't fit a neat box. That silence has a cost. Cardiologist Dr. Jayne Morgan joins us to explain why menopause is a cardiovascular turning point, and why so many women feel dismissed with “normal labs” while their bodies are waving real warning flags.In this episode, we talk about an uncomfortable truth: many clinicians receive little to no menopause training, and it still isn't meaningfully reflected in many clinical guidelines. Dr. Morgan breaks down how that gap leads to fragmented care, in which palpitations, dizziness, bloating, joint pain, or even itchy ears are treated as separate mysteries rather than a connected syndrome. We also unpack how language like “atypical” chest pain can quietly lower urgency for women, even though heart disease remains the number one killer of women, and risk can rise sharply during perimenopause as estrogen declines.Connect with Dr. Morgan at·       Facebook – https://www.facebook.com/FortyMIlionBeats/·       Instagram – https://www.instagram.com/drjaynemorgan/·       TikTok – https://www.tiktok.com/@DrJayneMorgan

In Part 2 of this 3-part series, experts from the MAPS Leadership and Management Domain continue this discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.

In this powerful live episode recorded at our live “Reality of Infertility” event in Los Angeles, Love is Blind Season 7 cast member, Monica Jade Davis shares the deeply personal story behind her fertility journey.Known to many from reality TV, Monica opens up about her relationship with partner Zac, their diagnosis of unexplained infertility, and the emotional reality of undergoing four back-to-back IVF cycles - including the highs of retrieving 90 eggs and the heartbreak of struggling to reach viable embryos.She talks candidly about:What surprised her most about IVFThe mental and emotional toll of repeated failed cyclesHow sharing her journey online transformed her connection to communityWhy she wishes she had frozen her eggs earlierAnd how she's learning to reclaim her identity outside of infertilityWhat carries Monica forward is a hard-earned belief that this chapter isn't the end of her story. If anything, this journey has deepened her dream of becoming a mother and strengthened her certainty that she will be one someday. Yet another chapter in her love story.This inspiring episode also features an informative mid-roll segment with episode sponsor, Tru Niagen. Mona Rosene, MS, RD, Global Director, Scientific & Medical Affairs, Niagen Bioscience​ educates us on the importance of NAD for issues like inflammation and to support mitochondrial and cellular health. Use our code EGGS20 at to get 20% off at TruNiagen.com. Hosted on Acast. See acast.com/privacy for more information.

At the 19th World Congress of the Societies of Anaesthesiologists (WCSA 2026) in Marrakesh, TopMedTalk welcomes Desiree Chappell back alongside Kate Leslie to interview Professor Palesa Motshabi-Chakane, Associate Professor and Head of Anaesthesiology at the University of the Witwatersrand and her colleague, Dr Mullai Slave a PhD candidate at University of the Witwatersrand. They discuss a study of 629 women undergoing cesarean section with spinal anesthesia at Chris Hani Baragwanath Hospital, where 23–33% are HIV positive. Using standard monitoring plus BD APM noninvasive continuous hemodynamic monitoring, they compared HIV-positive and HIV-negative patients and found higher hypotension incidence in HIV-positive women (68% vs 64%), with lower heart rate and lower cardiac index over 60 minutes. Additional testing included echocardiography with speckle tracking, pro-BNP, and autonomic assessments, with HIV-positive patients showing stiffer ventricles; Apgar scores did not differ. They discuss replication, multicenter research, and potential machine-learning tools to predict hypotension risk, and describe BD Advanced Patient Monitoring grant support enabling equipment, sensors, staffing, and training (~200 staff) to complete data collection in about six months. Edwards Lifesciences is now known as Becton Dickinson Advanced Patient Monitoring (BD APM). Desiree Chappell, former Co Editor in Chief of TopMedTalk, is now Director, Medical Science Liaison, Medical Affairs, BD Advanced Patient Monitoring. The views expressed on this program are her own and not those of her employers. We mention Adrian Gelb, if you'd like to hear his recent conversation with us go here: https://topmedtalk.libsyn.com/professor-adrian-gelb-on-patient-safety-and-essential-medicines-in-anaesthesia -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - https://ebpom.org/product/ebpom-world-congress-2026/  

What if the decisions that determine your drug's commercial success are already being made and medical affairs isn't in the room? In this episode of Medical Affairs Unscripted, Peg Crowley speaks with Nick Sen, SVP and Practice Lead at Lumanity Medical Affairs Consulting, about the evolving role of medical affairs as a strategic driver in biotech and pharmaceutical development. Drawing on experience across academia, commercial strategy, and market access, Nick explains why early medical engagement is no longer optional even for resource-constrained biotech companies. Instead, it is a critical lever for improving clinical, regulatory, and commercial outcomes. They explore three core pillars of medical affairs impact: De-risking clinical development by shaping the Target Product Profile (TPP) with real-world clinical and stakeholder insight Accelerating regulatory approval through early investigator engagement, site selection, and improved trial enrollment Enabling market access and adoption by building an evidence strategy aligned with payer, provider, and patient needs As scientific innovation accelerates across cell therapies, gene therapies, and complex biologics biotech companies must move beyond a narrow focus on regulatory approval and design development programs for real-world adoption and value demonstration. This episode is essential for biotech executives, medical affairs leaders, and cross-functional teams looking to integrate medical strategy earlier in clinical development and strengthen the probability of successful commercialization.

In this episode of Core Conversations with Natalie Baggio, we explore how clinical leadership and innovation are shaping the future of health care in Southwest Michigan. Natalie is joined by Dr. John Froggatt, Vice President of Medical Affairs and Infectious Disease Physician, who has practiced locally for 27 years. Dr. Froggatt shares exciting news about a new stroke treatment service launching soon - A procedure that physically removes blood clots in the brain, restoring blood flow quickly and improving outcomes. Offering this advanced care locally means faster treatment, saved lives, and fewer patients needing to leave the community during critical moments. The conversation also highlights powerful improvements in care for patients living with sickle cell disease. Through system-wide collaboration, new standards of care, and stronger outpatient connections, patients are experiencing fewer hospital visits, shorter stays, and better quality of life. Dr. Froggatt reflects on what makes his work most meaningful today, building high-performing physician teams, strengthening quality, and embracing new technologies like artificial intelligence to continuously improve patient care. Hear how thoughtful leadership, collaboration, and innovation are helping keep high-quality care close to home in Southwest Michigan.See omnystudio.com/listener for privacy information.

When "Denied" Goes Viral: AI Claim Denials, TrumpRx, and America's Healthcare Trust Crisis The Not Old Better Show, Art of Living Interview Series Thank you, I'm Paul Vogelzang. Today's episode is brought to you by Caraway. Good Looking. Clean Cooking. Have you ever stood at the pharmacy counter, card in hand, and heard one word: denied? For our listeners over 50, that moment isn't about inconvenience. It's blood pressure meds. It's insulin. It's the medication that keeps you steady, independent, and in your own life. And then comes the "solution": "Try a coupon." "Pay cash." "Use a marketplace." Behind that advice is a system that can feel like a black box—prior authorization, shifting formularies, and now, more and more, algorithms. AI can speed up decisions, but it can also shut a door without giving you a clear, human explanation. Now add the third ingredient: social media. A nonstop feed that can take real pain and turn it into a blame spiral—until people stop asking, "How do we fix this?" and start asking, "Who do we punish?" We've seen how fast outrage can spread, and how dangerous it can become when it's celebrated instead of cooled down. Today on The Not Old Better Show, we're connecting those dots—insurance hurdles, AI-driven denials, and the polarization that's eroding trust. Our guest is Dr. William Soliman, CEO of the Accreditation Council for Medical Affairs and a leading expert on pharma and health insurance. He'll explain TrumpRx—what it is, what it isn't, and why a discount price that doesn't count toward your deductible can backfire for seniors on multiple medications. We'll talk reform. We'll talk responsible tech. And we'll talk empathy—because healthcare can't run on anger. And it's never too late to insist on dignity at the doctor's office. Remember, support our sponsors: today's episode is brought to you by Caraway. Good Looking. Clean Cooking.

Bonus episode! I had the opportunity to talk to the folks at Dexcom about their presentations at ATTD and I wanted to bring you the interview sooner rather than later. ATTD is the Advanced Technology and Treatments for Diabetes conference, this year it took place in Barcelona. If you're new around here, there are a few big diabetes conferences where studies are presented and news is made. ATTD in spring, ADA and ADCES in summer and a few more scattered here and there. We'll be sharing more from ATTD in upcoming interviews with other tech companies. But today I'm talking to Jessica Castle, VP of Medical Affairs at Dexcom – she's also an adult endocrinologist with a lot of clinical trial experience. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Have you heard about Embody yet? It's a brand new platform that includes community support to assist you with maintaining a healthy lifestyle and overall well-being. Mark finds out the skinny with Dr. Brunilda Nazario,Chief Physician Editor, Medical Affairs at Web MD.

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and education space. The Perry Academy was created for

I am excited to welcome Dr. Jayne Morgan as my guest today. She is a cardiologist and the Vice President of Medical Affairs at Hello Heart, specializing in women's health and cardiovascular research. In our conversation, we look at the gaps in clinicians' training around perimenopause and menopause, also discussing gender neutral training, and how men and women are treated differently in the medical system. Dr. Morgan shares her preferred areas of focus when educating middle-aged women about hormone replacement therapy and clusters of diagnoses, which include diabetes, dyslipidemia, high blood pressure, and weight-loss resistance. We examine how myocardial infarctions (heart attacks) tend to manifest differently in women, often with microvascular disease, atypical chest pain, and less obvious symptom patterns. We also explore screening recommendations, such as EKGs, Lp(a) assessments, and mammography for microcalcifications, which might indicate an elevated risk for cardiovascular disease. This fun and lively conversation with Dr. Morgan offers valuable, practical insights into women's heart health. I look forward to recording future podcast episodes with her. IN THIS EPISODE, YOU WILL LEARN: One-size-fits-all treatment of women during medical training in the '90s and early 2000s Speaking up in the exam room when something doesn't feel right When hormone therapy was labeled dangerous, and the fallout that followed Medicine's uncomfortable truth: clinicians must keep learning or fall behind Gender-neutral cardiology and the women it left behind The midlife risk-factor pileup no one prepared women for  Why not taking blood pressure or cholesterol medications is risky rather than healthy Heart attacks often mistaken for anxiety, especially in women Slow change, real progress in women's cardiology care Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Jayne Morgan On Instagram, TikTok, Threads, YouTube, and LinkedIn

In this episode of Health Gig, Doro and Tricia welcome Dr. Eva Selhub, Chief of Medical Affairs at ForHumanity. Dr. Selhub talks about her journey within the medical field, which was shaped by personal experiences that led her to rethink traditional healthcare. Through her work at ForHumanity, she is an educator on personalized healthcare delivery and the significance of understanding bio-individuality. Dr. Selhub leaves listeners with the understating that while health comes from practice and medicines, true wellness stems from compassion and self-love.

Did you know that nearly 50% of women experience hair changes during menopause? In this expert-led conversation, we uncover the truth behind menopausal hair thinning, shedding, and texture changes with Dr. Isabelle Raymond, SVP of Clinical and Medical Affairs at Nutrafol. Dr. Raymond is dedicated to advancing women's health, with a particular focus on the biological and lifestyle factors that impact hair health during midlife. We explore the six root causes of hair thinning, the critical role of nutrition and hormones in hair growth, and why clinically backed research is essential for proven hair wellness solutions. Show Notes/Links: www.hotflashescooltopics.com Nutrafol: Link WE GREATLY APPRECIATE 5 STARS AND REVIEWS! Find Us Here! Website I [http://hotflashescooltopics.com/] Mail I [hotflashescooltopics@gmail.com] Instagram I [https://www.instagram.com/hotflashesandcooltopics/] Facebook : [www.facebook.com/hotflashescooltopics] YouTube I [https://www.youtube.com/@HotFlashesCoolTopics] Pinterest I [https://www.pinterest.com/hcooltopics/]

In this episode, Dr. Sriram Vissa, Chief Medical Officer and Vice President of Medical Affairs at SSM Health DePaul Hospital, shares how multidisciplinary teamwork and data driven care progression improved safety, efficiency, and length of stay, while outlining priorities for behavioral health access, workforce stability, and growth in 2026.

Your heart attack won't look like the movies—and that ignorance is killing women. Dr. Jayne Morgan, renowned cardiologist and VP of Medical Affairs at Hello Heart, shares a shocking truth: women wait 37 minutes longer for care than men, and each minute increases your risk of dying. Discover why fatigue and jaw pain might be your body's SOS, how menopause impacts your natural heart protection, and the one phrase that gets immediate ER attention. Heart disease is women's #1 killer, yet we're dismissed as "atypical." Arm yourself with knowledge that saves lives, beauties—starting now. FOLLOW A CERTAIN AGE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET INBOX INSPO: Sign up for our newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AGE BOLDLY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices